Drug Turns Cancer’s Defense Against It | Health and Fitness News

Scientists are revolutionizing mesothelioma treatment by turning cancer’s own survival tactics against it. A new experimental drug blocks PRX3, a key antioxidant cancer cells use to survive stress, causing lethal buildup of damaging molecules inside tumors. In early trials, it halted disease progression in 67% of patients, shrank tumors, and extended survival—especially in critically ill patients. Remarkably, healthy cells remain unaffected, and mice without PRX3 genes live normally, proving the target’s safety. The drug, derived from a natural antibiotic, is now advancing to phase two trials, with hopes of becoming an oral pill to treat other cancers too. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Sources: https://www.sciencedaily.com/releases/2026/09/260915232136.htm More coverage & latest updates: https://sources.thednn.ai/d0dc96ca8d6180a0 Report issues to [email protected].